Acute Porphyria Drug Database

J01DD14 - Ceftibuten
Propably not porphyrinogenic
PNP

Rationale
Probably not significantly metabolised. No data pointing to CYP-interaction. One reference: use with caution.
Chemical description
(To be edited, initial data ST OCT 04) Betalactamase stable antibiotic of cephalosporine type used in urinary tract infections, exacerbations of chronic bronchitis and in acute sinusitis, otitis media and pharyngotonsillitis where penicillins are ineffective. Metabolized only to a small extent, excreted by the kidneys in unchanged form. No indications for CYP-interaction. South African list: use with caution.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes J01D / J01DD or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙